What is Mydayis used for?

Mydayis is a prescription stimulant medication used to treat Attention Deficit Hyperactivity Disorder (ADHD) in adolescents aged 13 years and older, as well as adults, by improving focus, attention, and impulse control throughout the day.

• Mydayis helps manage core ADHD symptoms including inattention, hyperactivity, and impulsiveness that interfere with daily functioning.
• It is specifically approved for patients 13 years and older, unlike some other ADHD medications that start at younger ages.
• The medication provides symptom relief for up to 16 hours, making it suitable for people who need extended coverage from morning through afternoon or evening activities.
• Mydayis works by increasing levels of dopamine and norepinephrine in the brain to enhance executive function and behavioral control.
• It is not intended for use in children under 13 or for conditions other than ADHD unless directed by a healthcare provider.
• Mydayis is classified as a Schedule II controlled substance due to its potential for misuse and dependence.

How long does Mydayis last?

Mydayis is designed as an extended-release medication that provides symptom control for up to 16 hours after a single morning dose.

• The triple-bead release technology allows Mydayis to deliver the active ingredients in phases, extending its effects longer than many other ADHD stimulants.
• Most patients experience noticeable improvement in focus and behavior starting within 2-4 hours after taking the capsule.
• The full duration of 16 hours helps cover a typical school day, work day, or active period without requiring additional doses.
• Individual response times may vary slightly based on metabolism, food intake, and other personal factors.
• Taking Mydayis early in the morning maximizes daytime coverage while minimizing interference with evening sleep.
• If effects wear off earlier than expected, consult a healthcare professional rather than adjusting the dose independently.

What is the typical starting dose for Mydayis?

The typical starting dose of Mydayis is 12.5 mg taken once daily in the morning for both adolescents (13-17 years) and adults.

• This low starting dose allows the body to adjust to the medication while minimizing potential side effects.
• For adolescents aged 13-17, the maximum recommended dose is usually 25 mg per day after gradual titration if needed.
• Adults may have their dose increased in increments after at least one week, depending on response and tolerability.
• Mydayis capsules should be swallowed whole with water and taken at the same time each day for consistent effects.
• Dose adjustments should only be made under medical supervision to balance symptom control and side effect management.
• The 12.5 mg strength is available specifically to support this conservative starting approach.

Can Mydayis be taken with food?

Mydayis can be taken with or without food, as food does not significantly affect its overall absorption or effectiveness.

• High-fat meals may slightly delay the time to peak concentration but do not reduce the total amount absorbed.
• Acidic foods and drinks (such as citrus juices or sodas) should be avoided close to dosing time because they can decrease absorption of amphetamines.
• For best consistency, many people choose to take Mydayis at the same time each morning, regardless of meals.
• Taking it with a light breakfast can help reduce potential stomach upset for some users.
• Unlike some medications, Mydayis does not require food to prevent irritation or to enhance absorption.
• Always follow consistent timing and avoid drastic changes in diet that include large amounts of acidic items around dosing.

What are common side effects of Mydayis?

Common side effects of Mydayis include decreased appetite, trouble sleeping, dry mouth, nervousness, and weight loss, which are typical of stimulant medications used for ADHD.

• Decreased appetite often leads to reduced food intake and potential weight loss, especially during the first few weeks of treatment.
• Insomnia or difficulty falling asleep is frequent; taking the dose early in the morning helps reduce this effect.
• Dry mouth can be managed by staying hydrated, chewing sugar-free gum, or using saliva substitutes.
• Nervousness, anxiety, or jitteriness may occur as the body adjusts to the stimulant effects.
• Other frequent side effects include headache, abdominal pain, and increased heart rate or blood pressure.
• Most side effects are mild to moderate and tend to decrease over time as the body adapts to the medication.

How does Mydayis differ from Adderall XR?

Mydayis differs from Adderall XR primarily through its longer duration of action, lasting up to 16 hours compared to Adderall XR’s 10-12 hours, due to its unique triple-bead extended-release technology.

• Mydayis uses three distinct types of drug-releasing beads that provide an initial release, followed by two delayed releases for smoother and more prolonged coverage throughout the day.
• Adderall XR typically employs a double-bead system, resulting in a shorter overall duration that may require additional dosing for some patients needing all-day symptom control.
• Mydayis is approved only for ages 13 and older, while Adderall XR is approved for children as young as 6 years.
• Both medications contain similar mixed amphetamine salts, but Mydayis is formulated specifically for extended duration to better suit adolescents and adults with longer active periods.
• The longer effect of Mydayis often reduces the need for afternoon booster doses that some patients require with Adderall XR.
• Individual response varies, so switching between the two should be guided by symptom coverage needs and tolerability.

Is Mydayis a controlled substance?

Yes, Mydayis is classified as a Schedule II controlled substance under the Controlled Substances Act due to its high potential for abuse, dependence, and misuse.

• Schedule II classification means Mydayis has accepted medical use but also carries a significant risk of physical or psychological dependence when misused.
• It contains amphetamine salts, which are stimulants with a high abuse liability similar to other Schedule II ADHD medications like Adderall and Dexedrine.
• Prescriptions for Mydayis are typically limited in quantity, with no automatic refills allowed in most regions, requiring a new prescription for each fill.
• Possession without a valid prescription is illegal, and misuse can lead to serious legal and health consequences.
• Healthcare providers monitor patients closely for signs of dependence or diversion when prescribing Mydayis.
• The controlled status emphasizes the importance of using Mydayis exactly as directed to minimize risks.

Who should not take Mydayis?

Mydayis should not be taken by individuals with certain medical conditions, including advanced heart disease, severe hypertension, glaucoma, hyperthyroidism, or a history of drug abuse, unless specifically approved by a healthcare provider.

• People with structural cardiac abnormalities, cardiomyopathy, or serious heart rhythm problems face increased risk of sudden death or serious cardiovascular events when using stimulants like Mydayis.
• Those with moderate to severe hypertension or hyperthyroidism may experience dangerous elevations in blood pressure and heart rate.
• Mydayis is contraindicated in patients with glaucoma because amphetamines can increase intraocular pressure.
• Individuals with a history of substance use disorder or severe anxiety/agitation should avoid Mydayis due to its potential to exacerbate these conditions or lead to misuse.
• It is not recommended during or immediately after treatment with monoamine oxidase inhibitors (MAOIs) due to risk of hypertensive crisis.
• Pregnant or breastfeeding individuals should avoid Mydayis unless the potential benefits clearly outweigh the risks, as it may affect fetal development or pass into breast milk.

How should Mydayis capsules be stored?

Mydayis capsules should be stored at room temperature between 68°F to 77°F (20°C to 25°C), in a tightly closed container, away from moisture, heat, and direct light.

• Keep Mydayis in its original container with the child-resistant cap securely closed to maintain potency and prevent accidental access by children.
• Avoid storing the medication in bathrooms or other humid areas where moisture could degrade the extended-release beads.
• Protect the capsules from excessive heat sources such as direct sunlight, car interiors, or heaters, as high temperatures can affect the release mechanism.
• Do not transfer Mydayis to pill organizers or other unmarked containers, as this can lead to confusion or loss of potency tracking.
• Store out of reach and sight of children and pets to prevent accidental ingestion, given its Schedule II status.
• Check the expiration date regularly and properly dispose of expired or unused capsules through a take-back program rather than flushing or throwing in trash.

Can Mydayis cause sleep problems?

Yes, Mydayis can cause sleep problems such as insomnia or difficulty falling asleep, as it is a stimulant medication that increases alertness and brain activity.

• Insomnia is one of the most frequently reported side effects, especially when the dose is taken too late in the day or is too high for the individual.
• The long 16-hour duration means effects may still be active into the evening, potentially interfering with the natural wind-down process.
• Taking Mydayis as early as possible in the morning helps minimize impact on nighttime sleep for most users.
• Sleep disturbances often improve after the first few weeks as the body adjusts, but persistent issues may require dose adjustment or timing changes.
• Avoiding caffeine and other stimulants in the afternoon or evening can help reduce compounded effects on sleep.
• If sleep problems continue or worsen, consulting a healthcare provider is recommended to evaluate the need for changes in treatment approach.

Does Mydayis affect appetite?

Yes, Mydayis commonly affects appetite by significantly reducing it, which is a frequent side effect of stimulant medications used for ADHD treatment.

• Decreased appetite often occurs soon after starting Mydayis and can lead to noticeably lower food intake during the day.
• Many users experience this effect most strongly during the peak hours of the medication, typically in the morning and afternoon.
• Reduced appetite frequently results in weight loss, especially in the first few weeks or months of treatment as the body adjusts.
• Adolescents and adults alike report skipping meals or feeling less hungry, which may require conscious effort to maintain proper nutrition.
• The appetite suppression tends to be dose-dependent, so higher doses can intensify the effect.
• Strategies like eating nutrient-dense meals early in the day before the medication peaks or scheduling meals around dosing time can help manage this side effect.

What happens if a dose of Mydayis is missed?

If a dose of Mydayis is missed, skip the missed dose and take the next scheduled dose at the regular time the following day; never double the dose to make up for the missed one.

• Missing a single dose usually results in a return of ADHD symptoms such as difficulty focusing or increased impulsivity for that day.
• Because Mydayis has a long 16-hour duration, skipping one dose does not typically cause severe withdrawal but may lead to noticeable symptom rebound.
• Taking an extra dose to compensate can increase the risk of side effects like insomnia, anxiety, rapid heart rate, or overstimulation.
• Consistency is important for steady symptom control, so aim to take Mydayis at the same time each morning.
• If doses are frequently missed, discuss with a healthcare provider to explore reminders, adjustments, or alternative treatment options.
• In cases of multiple missed doses, resuming at the regular dose without doubling is generally the safest approach.

Is Mydayis suitable for adolescents?

Yes, Mydayis is suitable and FDA-approved for adolescents aged 13 to 17 years with ADHD, offering extended symptom control tailored to longer school and activity days.

• The approval for ages 13 and older distinguishes Mydayis from some other stimulants approved for younger children.
• Clinical studies demonstrated that Mydayis effectively reduces ADHD symptoms in adolescents while maintaining a safety profile similar to adults.
• The recommended starting dose for adolescents is 12.5 mg once daily, with a maximum of 25 mg per day after careful titration.
• Extended 16-hour coverage helps manage symptoms through school, after-school activities, and homework without needing multiple doses.
• Close monitoring is essential in this age group for growth, appetite, weight, sleep, and potential mood changes due to stimulant effects.
• Parents and healthcare providers should weigh benefits against risks, including cardiovascular monitoring and risk of misuse.

How does Mydayis work in the brain?

Mydayis works in the brain by increasing the levels of two key neurotransmitters—dopamine and norepinephrine—to improve attention, focus, impulse control, and executive functioning in people with ADHD.

• As a central nervous system stimulant, it blocks the reuptake of dopamine and norepinephrine while also promoting their release from nerve terminals.
• Higher dopamine levels enhance motivation, reward processing, and concentration in brain regions like the prefrontal cortex.
• Increased norepinephrine improves alertness, arousal, and the ability to filter distractions.
• The triple-bead extended-release formulation delivers these effects gradually over up to 16 hours for sustained symptom relief.
• Unlike short-acting stimulants, Mydayis provides a smoother profile with less pronounced peaks and troughs in neurotransmitter activity.
• This mechanism helps correct the neurochemical imbalances associated with ADHD without directly stimulating the entire nervous system excessively.

Can Mydayis be opened or sprinkled?

No, Mydayis capsules must be swallowed whole and should never be opened, crushed, chewed, or sprinkled, as this destroys the extended-release mechanism and can cause rapid release of the medication.

• The capsules contain specially designed beads that release the active ingredients in three phases over time.
• Opening or damaging the capsule results in immediate release of the full dose, which can lead to dangerously high peak levels, increased side effects, and potential overdose symptoms.
• Rapid release may cause severe restlessness, rapid heartbeat, high blood pressure, anxiety, or even more serious cardiovascular events.
• Unlike some extended-release formulations that allow sprinkling on food, Mydayis is not designed or approved for this method.
• Always take the capsule intact with water, and if swallowing is difficult, consult a healthcare provider for alternative ADHD treatment options.
• Proper administration ensures the intended 16-hour duration and safer, more consistent symptom control.